Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-22
1998-04-07
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514291, 514361, 514364, 544236, 544280, 544281, 546 80, 546118, 548122, 548129, 548132, A61K 31435, A61K 3142, C07D47104, C07D28508
Patent
active
057365555
ABSTRACT:
##STR1## Compounds shown by the above formula or salt thereof show a strong angiotensin II antagonistic activity and hypotensive action and CNS activity, and are useful as therapeutic agents of circulatory diseases such as hypertensive diseases and heart diseases (e.g. hypercardia, heart failure, cardiac infarction), strokes, cerebral apoplexy, nephritis, atherosclerosis, Alzheimer's disease, senile dementia, etc.
REFERENCES:
patent: 4880804 (1989-11-01), Carini et al.
patent: 5196444 (1992-03-01), Naka et al.
patent: 5268375 (1993-12-01), Bernhart et al.
patent: 5354766 (1994-10-01), Naka et al.
patent: 5412097 (1995-05-01), Chakravarty et al.
patent: 5559233 (1996-09-01), Bernhart et al.
patent: 5583141 (1996-12-01), Naka et al.
Inada Yoshiyuki
Naka Takehiko
Dentz Bernard
Takeda Chemical Industries Ltd.
LandOfFree
Heterocyclic compounds and their use as angiotensin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds and their use as angiotensin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds and their use as angiotensin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-13980